The new frontier for oncology PCI series event brings together industry thought leaders for a deep dive on emerging therapies like ADCs, oligonucleotides, radiopharmaceuticals, and advanced biologics, along with insights into patient-centric drug delivery technologies such as wearable and combination devices.
Our Ypsomed expert Ralf Kuenzi will be speaking on a range of topics, including strategies to improve adherence in self-care, the importance of patient feedback, and balancing regulatory, commercial and sustainability requirements in device strategy.
See you in Basel this June to connect, learn and innovate.
Our speaker at the conference
Ralf Kuenzi
Ralf Kuenzi is a Director at Ypsomed with roles in account management & business development focusing on strategic partnerships with key accounts as well as networking partners. Before re-joining Ypsomed in 2022, he was leading the ophthalmology & medical business segments at the primary packaging specialist Hoffmannn Neopac for 10 years. Prior to this engagement he worked at Disetronic/Ypsomed in various product, key account & business development roles for 16 years. He has a professional background in life sciences & holds a business management diploma from the Open University, UK.
